Figure 1From: Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effectsBaseline treatment workflow. Patients with no 3-vessel disease are treated with drug-eluting stents (DES). For the remaining patients we assumed that a fraction of them (λ) would be eligible for both DES and coronary artery bypass grafting (CABG); hence, we assumed that half of these patients are treated with DES and the other half with CABG.Back to article page